$LH News

LH or CRL: Which Is the Better Value Stock Right Now?

Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026

Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test

Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services Stocks

Is it the Right Time to Add Labcorp Stock to Your Portfolio?

3 Reasons LH is Risky and 1 Stock to Buy Instead

Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test

Labcorp Announces Nationwide Availability Of ColoSense, Its RNA-Based, At-Home Colorectal Cancer Screening Test

LH vs. CRL: Which Stock Is the Better Value Option?

Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Assessing Labcorp (LH) Valuation As Shares Cool And P/E Trails Healthcare Peers

LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

Labcorp Enters Collaboration The Alliance For Clinical Trials In Oncology To Advance A National, Multicenter Clinical Trial For Patients Newly Diagnosed With Colorectal Cancer

Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects

Labcorp Announces Availability Of Expanded DPYD Genotyping Test To Help Identify Cancer Patients At Increased Risk For Severe Fluoropyrimidine Chemotherapy Side Effects

LH or MEDP: Which Is the Better Value Stock Right Now?

Labcorp to Present at the Jefferies Global Healthcare Conference

What Are Wall Street Analysts' Target Price for Labcorp Holdings Stock?

Should Income Investors Look At Labcorp Holdings Inc. (NYSE:LH) Before Its Ex-Dividend?